Oric Pharmaceuticals Correlations
ORIC Stock | USD 9.80 0.07 0.71% |
The current 90-days correlation between Oric Pharmaceuticals and Cullinan Oncology LLC is -0.06 (i.e., Good diversification). The correlation of Oric Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Oric Pharmaceuticals Correlation With Market
Weak diversification
The correlation between Oric Pharmaceuticals and DJI is 0.38 (i.e., Weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Oric Pharmaceuticals and DJI in the same portfolio, assuming nothing else is changed.
Oric |
Moving together with Oric Stock
Moving against Oric Stock
0.54 | KZR | Kezar Life Sciences | PairCorr |
0.45 | KB | KB Financial Group | PairCorr |
0.41 | VFS | VinFast Auto | PairCorr |
0.39 | AA | Alcoa Corp Fiscal Year End 15th of January 2025 | PairCorr |
0.37 | T | ATT Inc Sell-off Trend | PairCorr |
0.35 | CVX | Chevron Corp Fiscal Year End 7th of February 2025 | PairCorr |
0.34 | BAC | Bank of America Aggressive Push | PairCorr |
0.34 | JPM | JPMorgan Chase Sell-off Trend | PairCorr |
0.33 | HPQ | HP Inc | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Oric Stock performing well and Oric Pharmaceuticals Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Oric Pharmaceuticals' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
SEER | 2.22 | 0.52 | 0.21 | 0.74 | 1.79 | 6.32 | 15.38 | |||
ANEB | 5.13 | (0.43) | 0.00 | (0.16) | 0.00 | 8.61 | 76.00 | |||
CGEM | 2.87 | (0.46) | 0.00 | 2.44 | 0.00 | 5.88 | 17.85 | |||
CCCC | 3.58 | (0.68) | 0.00 | (0.39) | 0.00 | 7.69 | 23.66 | |||
MOLN | 4.69 | (0.09) | (0.01) | 0.05 | 5.04 | 9.61 | 52.92 | |||
MLYS | 2.66 | (0.09) | 0.02 | 0.08 | 3.42 | 6.27 | 20.98 | |||
ANTX | 1.95 | 0.31 | 0.10 | 0.49 | 1.86 | 3.73 | 28.03 | |||
PHVS | 3.03 | 0.32 | 0.12 | 0.33 | 2.98 | 7.76 | 21.41 | |||
PEPG | 3.08 | (1.26) | 0.00 | (0.64) | 0.00 | 4.75 | 26.81 |